UNSPSC 51182110: Desmopressin acetate trihydrate

This classification denotes an antidiurectic hormone analogue with the molecular formula C46H64N14O12S2.C2H4O2.3H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XB13HYU18U, chemically known as vasopressin, 1-(3-mercaptopropanoic acid)-8-d-arginine-, monoacetate (salt), trihydrate, but more generally known as desmopressin acetate trihydrate, which bears US NIH Compound Identifier 64759.

UNSPSC 51182110 Desmopressin acetate trihydrate is a Commodity code encompassing the supply of this synthetic antidiuretic hormone medication to state and local health systems and facilities. State and local procurement under this code centers on generic pharmaceutical sourcing through cooperative purchasing agreements and multi-source drug supply contracts, where jurisdictions leverage group buying power to negotiate volume pricing and ensure consistent availability of essential medications across participating providers. Issuing bodies include state departments of administration and health, county health systems, municipal clinics, and other state and local government facilities that operate or support healthcare delivery. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is a key repeat buyer managing consolidated contracts that serve multiple participating states.

MMCAP's January 2026 Request for Proposal for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) represents current procurement activity under this code. The RFP establishes multiple contracts effective July 1, 2026, for a two-year initial term with optional extensions, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC) and to maintain comprehensive product information by National Drug Code, pricing flexibility through multiple formats (flat price, net price, WAC-minus), cGMP certification, and DSCSA compliance. Evaluation weights favor price competitiveness (75 percent), with secondary scoring on fixed pricing, EDI capability, and administrative fee structure. The RFP covers participating states including Minnesota and Oregon, with vendors subject to a 3 percent administrative fee and performance penalties ranging from $200 to $1,500 per violation. Submissions require Google Chrome access to the ePro procurement system and delivery by March 26, 2026, with a February 18, 2026 cutoff for vendor questions.